Volume 68, Issue 1, Pages (July 2005)

Slides:



Advertisements
Similar presentations
Volume 62, Issue 6, Pages (December 2002)
Advertisements

Volume 65, Issue 1, Pages (January 2004)
Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-α produced by renal parenchymal cells  B. Zhang, G. Ramesh, C.C. Norbury, W.B. Reeves 
Volume 63, Issue 6, Pages (June 2003)
Volume 64, Issue 6, Pages (December 2003)
Volume 64, Issue 5, Pages (November 2003)
Systemic Administration of Multipotent Mesenchymal Stromal Cells Reverts Hyperglycemia and Prevents Nephropathy in Type 1 Diabetic Mice  Fernando E. Ezquer,
Volume 78, Issue 11, Pages (December 2010)
Volume 85, Issue 4, Pages (April 2014)
Volume 62, Issue 1, Pages (July 2002)
The Case ∣ Acute renal failure and anemia
Volume 74, Issue 10, Pages (November 2008)
Volume 61, Issue 4, Pages (April 2002)
Volume 79, Issue 9, Pages (May 2011)
Volume 76, Issue 5, Pages (September 2009)
Volume 61, Issue 2, (February 2002)
Volume 83, Issue 5, Pages (May 2013)
Volume 65, Issue 1, Pages (January 2004)
Volume 68, Issue 5, Pages (November 2005)
Volume 66, Issue 6, Pages (December 2004)
Adenovirus-mediated kallikrein gene delivery reverses salt-induced renal injury in Dahl salt-sensitive rats  Julie Chao, Jenny J. Zhang, Kuei-Fu Lin,
C.-W. Tsai, V.-C. Wu, W.-C. Lin, J.-W. Huang, M.-S. Wu
Volume 54, Issue 5, Pages (November 1998)
Kidney involvement in a nongenetic rat model of type 2 diabetes
Volume 63, Issue 6, Pages (June 2003)
Volume 70, Issue 7, Pages (October 2006)
Volume 69, Issue 1, Pages (January 2006)
Yang Wang, Yi Ping Wang, Yuet-Ching Tay, David C.H. Harris 
The clinical spectrum of tubulointerstitial nephritis
Volume 63, Issue 5, Pages (May 2003)
Volume 57, Issue 2, Pages (October 2000)
Volume 70, Issue 2, Pages (July 2006)
Inhibition of nuclear factor-κB activation reduces cortical tubulointerstitial injury in proteinuric rats  Gopala K. Rangan, Yiping Wang, Yuet-Ching Tay,
Volume 66, Issue 6, Pages (December 2004)
Volume 60, Issue 6, Pages (December 2001)
Renoprotective role of the vitamin D receptor in diabetic nephropathy
Volume 67, Issue 2, Pages (February 2005)
Volume 79, Issue 10, Pages (May 2011)
Role of CD8+ cells in the progression of murine adriamycin nephropathy
Deletion of the epidermal growth factor receptor in renal proximal tubule epithelial cells delays recovery from acute kidney injury  Jianchun Chen, Jian-Kang.
Volume 56, Issue 5, Pages (November 1999)
Volume 70, Issue 2, Pages (July 2006)
Volume 73, Issue 12, Pages (June 2008)
Volume 56, Issue 4, Pages (October 1999)
Resistance to ischemic acute renal failure in the Brown Norway rat: A new model to study cytoprotection  David P. Basile, Deborah Donohoe, X.I.A. Cao,
Volume 56, Issue 3, Pages (September 1999)
Volume 59, Issue 3, Pages (March 2001)
Volume 84, Issue 4, Pages (October 2013)
Volume 53, Issue 4, Pages (April 1998)
An unusual cause of acute renal failure
Volume 67, Issue 2, Pages (February 2005)
C5b-9 regulates peritubular myofibroblast accumulation in experimental focal segmental glomerulosclerosis  Gopala K. Rangan, Jeffrey W. Pippin, William.
Volume 66, Issue 4, Pages (October 2004)
Volume 71, Issue 9, Pages (May 2007)
Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis  H.-C. Yang, L.-J. Ma, J. Ma, A.B. Fogo 
Volume 57, Issue 2, Pages (October 2000)
Volume 80, Issue 5, Pages (September 2011)
Volume 60, Issue 6, Pages (December 2001)
LncRNA ZEB1-AS1 Was Suppressed by p53 for Renal Fibrosis in Diabetic Nephropathy  Juan Wang, Jian Pang, Huiling Li, Jie Long, Fang Fang, Junxiang Chen,
MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis  Sang-Kyung Jo, Won Yong Cho, Su Ah Sung, Hyoung.
Volume 76, Issue 1, Pages 6-7 (July 2009)
H. Raffi, J.M. Bates, Z. Laszik, S. Kumar  Kidney International 
Volume 69, Issue 3, Pages (February 2006)
Effects of cyclosporine in osteopontin null mice1
Volume 62, Issue 1, Pages (July 2002)
Volume 67, Issue 6, Pages (June 2005)
The more or less ‘pristine’ renal allograft biopsy
J.S. Schlondorff, G.P. Mendez, H.G. Rennke, C.C. Magee 
The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury?  Richard E. Gilbert, Mark E. Cooper  Kidney.
Volume 70, Issue 1, Pages (July 2006)
Presentation transcript:

Volume 68, Issue 1, Pages 391-398 (July 2005) Can murine diabetic nephropathy be separated from superimposed acute renal failure?  Yuet-Ching Tay, Yiping Wang, Lukas Kairaitis, Gopala K. Rangan, Chun Zhang, David C.H. Harris  Kidney International  Volume 68, Issue 1, Pages 391-398 (July 2005) DOI: 10.1111/j.1523-1755.2005.00405.x Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 1 Comparison of histologic changes in periodic acid-Schiff (PAS)-stained renal cortical sections from BALB/c mice (A to D and F) and C57BL/6J mice (E). (A) Without any injection. (B to D) with a single high dose of streptozotocin (STZ) (225mg/kg intraperitoneally, (F) with two low doses of STZ (75mg, 150mg/kg intravenously, and (E) with a single high dose of STZ (200mg/kg) intravenously. Diabetic animals maintained at normoglycemia were sacrificed at week 2 (D), while those maintained at hyperglycemia were sacrificed at week 1 (B) and week 2 (C, E, and F). The arrowed tubules in (B to E) show denudation of the epithelial cells consistent with acute tubular necrosis (ATN). Arrowheads (F) denote interstitial cell infiltrates (magnification 400×). Kidney International 2005 68, 391-398DOI: (10.1111/j.1523-1755.2005.00405.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 2 Urinary glucose, μmol/16 hours (A), serum creatinine, μmol/L (B), creatinine clearance, mL/minute (C), for normal and diabetic BALB/c mice (regimen B, 75mg, 150mg/kg streptozocin (STZ) intravenously sacrificed at weeks (w) 1, 2, 4, and 8 post-STZ. Values are expressed as mean ± SD. *P <.05; **P < 0.001 when compared to normal animals. Kidney International 2005 68, 391-398DOI: (10.1111/j.1523-1755.2005.00405.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 3 Comparison of histologic changes in periodic acid-Schiff (PAS)-stained renal sections from BALB/c mice (A) without any injection, (B and C) injected with two low doses of streptozotocin (STZ) (75mg, 150mg/kg intravenously). Diabetic mice were maintained at hyperglycemia. Arrows denote interstitial cell infiltrates at week 2 (B) and glomerulosclerosis at week 8 (C) (magnification 400×). Kidney International 2005 68, 391-398DOI: (10.1111/j.1523-1755.2005.00405.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 4 Morphometric analysis of normal and diabetic BALB/c mice sacrificed at weeks (w) 1, 2, 4 and 8 after induction of diabetes with 75mg, 150mg/kg streptozotocin (STZ). Diabetic mice were maintained at hyperglycemia prior to sacrifice. (A) Cortical tubular cell height, μm. (B) Glomerular area, μm2. (C) Glomerulosclerosis index [% of periodic acid-Schiff (PAS) material in tuft]. (D) Interstitial area (% of cortex). Values are expressed as mean ± SD. *P < 0.05; **P < 0.005. Kidney International 2005 68, 391-398DOI: (10.1111/j.1523-1755.2005.00405.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 5 Stained renal cryosections from BALB/c mice, sacrificed at week 2, (A, C, and E) without any injection; (B, D, and F) with two low doses of streptozotocin (STZ) (75mg, 150mg/kg intravenously) and maintained at hyperglycemia. (A and B) Stained for CD4. (C and D) Stained for CD8. (E and F) Stained for macrophage. Arrows denote respective cell surface markers (magnification 400×). Kidney International 2005 68, 391-398DOI: (10.1111/j.1523-1755.2005.00405.x) Copyright © 2005 International Society of Nephrology Terms and Conditions